Библиотека

Я ненавижу тебя, только не бросай меня. Пограничные личности и как их понять стр. 129

Размер шрифта
-
+
Тема

Otto F. Kernberg, A Primer for Transference-Focused Psychotherapy for the Borderline Patient (Lanham, MD: Jason Aronson, 2002).

135

Robert J. Gregory and Anna L. Remen, “A Manual-Based Psychodynamic Therapy for Treatment-Resistant Borderline Personality Disorder,” Psychotherapy: Theory, Research, Practice, Training 45 (2008): 15–27.

136

Eric M. Plakun, “Making the Alliance and Taking the Transference in Work with Suicidal Borderline Patients,” Journal of Psychotherapy Practice and Research 10 (2001): 269–276.

137

Allan Abbass, Albert Sheldon, John Gyra, et al., “Intensive Short-Term Dynamic Psychotherapy for DSM-IV Personality Disorders: A Randomized Controlled Trial,” Journal of Nervous and Mental Disease 196 (2008): 211–216.

138

Antonio Menchaca, Orietta Perez, and Astrid Peralta, “Intermittent-Continuous Eclectic Therapy: A Group Approach for Borderline Personality Disorder,” Journal of Psychiatric Practice 13 (2007): 281–284.

139

John F. Clarkin, Kenneth N. Levy, Mark F. Lenzenweger, et al., “Evaluating Three Treatments for Borderline Personality Disorder: A Multiwave Study,” American Journal of Psychiatry 164 (2007): 922–928.

140

Josephine Giesen-Bloo, Richard van Dyck, Philip Spinhoven, et al., “Outpatient Psychotherapy for Borderline Personality Disorder: Randomized Trial of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” Archives of General Psychiatry 63 (2006): 649–658.

141

Antoinette D. I. van Asselt and Carmen D. Dirksen, “Outpatient Psychotherapy for Borderline Personality Disorder: Cost-Effectiveness of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” British Journal of Psychiatry 192 (2008): 450–457.

142

Ted Reichborn-Kjennerud, “Genetics of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 421–440.

143

Randy A. Sansone and Lori A. Sansone, “The Families of Borderline Patients: The Psychological Environment Revisited,” Psychiatry 6 (2009): 19–24.

144

Bernadette Grosjean and Guochuan E. Tsai, “NMDA Neurotransmission as a Critical Mediator of Borderline Personality Disorder,” Journal of Psychiatry and Neuroscience 32 (2007): 103–115.

145

Antonia S. New, Marianne Goodman, Joseph Triebwasser, et al., “Recent Advances in the Biological Study of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 441–461.

146

Bonnie Jean Steinberg, Robert L. Trestman, and Larry J. Siever, “The Cholinergic and Noradrenergic Neurotransmitter Systems and Affective Instability in Borderline Personality Disorder,” in Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 41–62.

147

Mary C. Zanarini, Catherine R. Kimble, and Amy A. Williams, “Neurological Dysfunction in Borderline Patients and Axis II Control Subjects,” Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 159–175.

148

Jose Manuel de la Funete, Julio Bobes, Coro Vizuete, et al., “Neurologic Soft Signs in Borderline Personality Disorder,” Journal of Clinical Psychiatry 67 (2006): 541–546.

149

Eric Lis, Brian Greenfield, Melissa Henry, et al., “Neuroimaging and Genetics of Borderline

Personality Disorder: A Review,” Journal of Psychiatry and Neuroscience 32 (2007): 162–173.

150

American Psychiatric Association, “Practice Guideline for the Treatment of Patients with Borderline Personality Disorder,” American Journal of Psychiatry 158 (2001, October Supplement).

151

Mary C. Zanarini and Frances R. Frankenburg, “Omega-3 Fatty Acid Treatment of Women with Borderline Personality Disorder: A Double-Blind Placebo-Controlled Pilot Study,” American Journal of Psychiatry 160 (2003): 167–169.

152

Christopher Pittenger, John H. Krystal, and Vladimir Coric, “Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated with Borderline Personality Disorder” (Letter to the Editor), Journal of Clinical Psychiatry 66 (2005): 1492–1493.

Переход на страницу
Ваш комментарий
Рейтинг

Имя, оценка и комментарий будут опубликованы после модерации. Не указывайте личные данные. Политика конфиденциальности.